To include your compound in the COVID-19 Resource Center, submit it here.

Aviscumine: Phase II data

An open-label, German Phase II trial in 31 patients with unresectable stage IV metastatic

Read the full 144 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE